Rock Springs Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-835,776	Closed	-$49.1M	–	119
2023 Q4	$49.1M	Sell	835,776 -295,431	-26%	-$17.4M	1.21%	27
2023 Q3	$49.3M	Buy	1,131,207 +9,560	+0.9%	+$416K	1.32%	27
2023 Q2	$40.5M	Buy	1,121,647 +56,386	+5%	+$2.04M	0.96%	36
2023 Q1	$39.6M	Buy	1,065,261 +260,237	+32%	+$9.68M	0.95%	38
2022 Q4	$36.5M	Sell	805,024 -61,752	-7%	-$2.8M	0.88%	41
2022 Q3	$60.5M	Buy	866,776 +21,799	+3%	+$1.52M	1.56%	19
2022 Q2	$56.7M	Buy	844,977 +285,243	+51%	+$19.1M	1.65%	18
2022 Q1	$46M	Buy	559,734 +149,319	+36%	+$12.3M	1.16%	32
2021 Q4	$60.2M	Buy	410,415 +56,901	+16%	+$8.35M	1.39%	20
2021 Q3	$62.5M	Buy	353,514 +34,429	+11%	+$6.09M	1.32%	24
2021 Q2	$51.5M	Sell	319,085 -4,562	-1%	-$737K	1.02%	30
2021 Q1	$55.4M	Sell	323,647 -49,505	-13%	-$8.48M	1.21%	26
2020 Q4	$82M	Buy	373,152 +24,391	+7%	+$5.36M	1.74%	12
2020 Q3	$57.9M	Hold	348,761	–	–	1.47%	18
2020 Q2	$39.8M	Buy	348,761 +7,261	+2%	+$829K	1.09%	34
2020 Q1	$26.3M	Buy	341,500 +41,500	+14%	+$3.19M	1.09%	37
2019 Q4	$38.7M	Buy	300,000 +42,500	+17%	+$5.48M	1.22%	24
2019 Q3	$20.1M	Buy	257,500 +55,000	+27%	+$4.29M	0.8%	48
2019 Q2	$20.9M	Buy	202,500 +22,500	+13%	+$2.32M	0.75%	49
2019 Q1	$13.2M	Buy	180,000 +30,000	+20%	+$2.2M	0.51%	65
2018 Q4	$6.36M	Sell	150,000 -90,000	-38%	-$3.82M	0.3%	85
2018 Q3	$11.3M	Hold	240,000	–	–	0.41%	79
2018 Q2	$11.8M	Buy	240,000 +51,000	+27%	+$2.51M	0.46%	75
2018 Q1	$5.8M	Buy	189,000 +9,000	+5%	+$276K	0.25%	110
2017 Q4	$3.29M	Buy	+180,000	New	+$3.29M	0.15%	120